EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study

F Ciccarone iD, G Zinicola iD, E H Tran iD, G Baldassari iD, E Boccia iD, C Nero iD, F Moro iD, T Pasciuto iD, G Scambia iD, G Ferrandina iD, A Fagotti iD, A C Testa iD und 2 weitere

Ultrasound in Obstetrics & Gynecology · 2026-10 · 68 (4) · 559-570

DOI: 10.1002/uog.70331 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 13.09.2026. Verfasst von F Ciccarone und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman and Child Health, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify ultrasound‐based radiomics features capable of distinguishing between high‐grade serous ovarian carcinomas (HGSC) and invasive low‐grade serous ovarian carcinomas (LGSC), and to develop machine‐learning models that include radiomics features to discriminate between the two.

Methods

This was a single‐center, analytical, observational, retrospective pilot study of patients referred to Fondazione Policlinico Universitario ‘A. Gemelli’ IRCCS, Rome, Italy, between January 2014 and June 2022 with a histological diagnosis of HGSC or invasive LGSC, who had DICOM images available from a preoperative ultrasound examination. The extracted radiomics features belonged to two different families: intensity‐based statistical features and textural features. Feature selection was performed via univariate analysis using the Wilcoxon–Mann–Whitney statistical test, followed by multivariate selection using the Boruta algorithm, Pearson correlation analysis to reduce collinearity and Akaike information criterion stepwise regression. Selected features were used to train logistic regression models. To distinguish between HGSC and LGSC, two logistic regression models were developed: a radiomics model based solely on radiomics features, and a clinical–radiomics model combining radiomics features with patient age. For comparison, two additional models were constructed: a radiomics–ultrasound model incorporating radiomics features and ultrasound variables that were significantly different between the two histotypes, and an ultrasound model based exclusively on these ultrasound variables. The area under the receiver‐operating‐characteristics (ROC) curve (ROC‐AUC) and the area under the precision‐recall (PR) curve (PR‐AUC) were calculated. Modeling results were internally validated via the bootstrap resampling method, and optimism‐corrected metrics were computed.

Results

A total of 153 patients (120 with a histological diagnosis of HGSC and 33 with a histological diagnosis of invasive LGSC) were recruited, providing a total of 332 images for analysis. For each image, 75 radiomics features were extracted. After feature selection, three textural features, ‘gray‐level co‐occurrence matrix informational measure of correlation 2’ (‘F_cm.info.corr.2’), ‘gray‐level run length matrix run percentage’ (‘F_rlm.r.perc’) and ‘gray‐level size zone matrix zone size variance’ (‘F_szm.zs.var’) were used for the radiomics model; one textural feature (F_szm.zs.var) and age were used for the clinical–radiomics model; one textural feature (F_cm.info.corr.2) and one ultrasound variable (color score) were used for the radiomics–ultrasound model; and three ultrasound variables (color score, presence of papillary projections, presence of the ovarian crescent sign) were used for the ultrasound model. The internally validated (optimism‐corrected) ROC‐AUC was 0.69 (95% CI, 0.57–0.77) for the radiomics model, 0.80 (95% CI, 0.72–0.90) for the clinical–radiomics model, 0.68 (95% CI, 0.56–0.77) for the radiomics–ultrasound model and 0.78 (95% CI, 0.68–0.88) for the ultrasound model. The clinical–radiomics model performed similarly to the ultrasound model (optimism‐corrected ROC‐AUC, 0.80 vs 0.78; P = 0.726) and better than the radiomics (optimism‐corrected ROC‐AUC, 0.80 vs 0.69; P = 0.042) and radiomics–ultrasound (optimism‐ corrected ROC‐AUC, 0.80 vs 0.68; P = 0.048) models.

Conclusions

Our findings indicate that, despite detectable differences in radiomics features between HGSC and LGSC, current radiomics and imaging‐based approaches do not provide sufficient added value over conventional ultrasound for reliable preoperative discrimination. Future research may be necessary to develop more accurate and clinically useful artificial intelligence‐based predictive models. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCystadenocarcinoma, SerousHumansFemaleRadiomicsPilot ProjectsRetrospective StudiesUltrasonographyNeoplasm GradingMiddle AgedDiagnosis, DifferentialAgedROC CurveMachine LearningAdult

Stichwörter der Autor:innen

high‐grade serous ovarian cancerlow‐grade serous ovarian cancerradiomicsultrasonography

Autor:innen und Institutionen

  • Department of Woman and Child Health, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Radiomics G-STeP Research Core Facility, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Section of Obstetrics and Gynecology, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
  • G-AURIG - Gemelli Advanced Ultrasound Research and Innovation Group, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Research core facility Data Collection G-STeP, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.

ORCID-Profile: F Ciccarone, G Zinicola, E H Tran, G Baldassari, E Boccia, C Nero, F Moro, T Pasciuto, G Scambia, G Ferrandina, A Fagotti, A C Testa, D Lorusso

Zitieren

APA

Ciccarone, F., Zinicola, G., Tran, E. H., Baldassari, G., Boccia, E., Nero, C., Moro, F., Pasciuto, T., Scambia, G., Ferrandina, G., Fagotti, A., Testa, A. C., Lorusso, D., & Collaborators (2026). Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study. Ultrasound in Obstetrics & Gynecology, 68(4), 559-570. https://doi.org/10.1002/uog.70331

Vancouver

Ciccarone F, Zinicola G, Tran EH, Baldassari G, Boccia E, Nero C, et al. Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study. Ultrasound in Obstetrics & Gynecology. 2026;68(4):559-570. doi:10.1002/uog.70331

BibTeX
@article{Ciccarone2026,
  author = {Ciccarone, F and Zinicola, G and Tran, E H and Baldassari, G and Boccia, E and Nero, C and Moro, F and Pasciuto, T and Scambia, G and Ferrandina, G and Fagotti, A and Testa, A C and Lorusso, D and Collaborators, Collaborators},
  title = {Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  volume = {68},
  number = {4},
  pages = {559--570},
  doi = {10.1002/uog.70331}
}
Kostenlos starten →